AI-generated summary
The authors ran a randomized clinical trial of photobiomodulation with 808 nm infrared light, an occlusal splint, or both, in 99 people with muscular temporomandibular disorder. They report significant pain reduction in the laser and combined groups, with the combination more effective than the splint alone in the first two weeks, and improved mouth opening and quality of life across groups.
- Participants
- 99
- Who or what was studied
- Adults diagnosed with muscular temporomandibular disorder using the Diagnostic Criteria for TMD; mean age 31.54 years, 80 women and 19 men
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract does not describe limits of the trial beyond its randomized design and the reported statistical comparisons.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation therapy, Visual analogue scale, Low-level laser therapy, Photobiomodulation, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.